Drd1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Major dopamine receptor in the striatum mediating motor control and reward
The DRD1 gene (Dopamine D1 Receptor) is located on chromosome 5q34 and encodes a protein involved in G protein-coupled receptor signaling. This gene has been implicated in several neurodegenerative diseases and neuropsychiatric disorders.
| Attribute | Value |
|---|---|
| Symbol | DRD1 |
| Full Name | Dopamine D1 Receptor |
| Chromosomal Location | 5q34 |
| NCBI Gene ID | 1812 |
| OMIM | 126449 |
| Ensembl ID | ENSG00000184845 |
| UniProt ID | P21728 |
The DRD1 gene encodes the dopamine D1 receptor, the most abundant dopamine receptor in the mammalian brain. It is a Gs-coupled GPCR that increases cAMP levels upon dopamine binding. D1 receptors are essential for motor control, reward processing, working memory, and motivated behavior. In the striatum, D1-expressing medium spiny neurons form the direct pathway, promoting movement initiation. In Alzheimer's disease, D1 receptor availability correlates with cognitive performance. In Parkinson's disease, D1 receptors are targets for dopaminergic therapy, but their stimulation can contribute to dyskinesias.
The DRD1 gene has been linked to the following diseases:
Highest expression in striatum (caudate nucleus, putamen, nucleus accumbens), olfactory tubercle, and frontal cortex. Moderate expression in substantia nigra pars compacta, ventral tegmental area, hippocampus (CA1, dentate gyrus), and prefrontal cortex. Low expression in cerebellum and brainstem.
D1 agonists (apomorphine, bromocriptine) used in Parkinson's disease. Dopamine replacement therapy (levodopa) indirectly activates D1 receptors. D1 antagonists used in schizophrenia but can cause parkinsonism. Dysbindin and other modulators in development. Direct D1 agonists investigated for cognitive enhancement in AD.
The study of Drd1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
DRD1 mutations and variants are associated with:
D1 receptor modulators in development:
DRD1 knockout mice show: